Curis Lifesciences Ltd
NSE: CURIS
₹106.75
₹-3.25
(-2.95%)
As on 10-Jun-2026 13:02IST
Market cap
₹89 Cr
Revenue (TTM)
₹49 Cr
P/E Ratio
12.9
P/B Ratio
1.9
Div. Yield
0 %
Quality Score
6/10
Growth Score
5/10
Valuation Score
7/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹6 Cr
-
ROE
55.2 %
-
ROCE
34.3 %
-
Industry P/E
44.89
-
EV/EBITDA
9.1
-
Debt to Equity
1
-
Book Value
₹27.3
-
EPS
₹10.3
-
Face value
10
-
Shares outstanding
8,084,434
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Curis Lifesciences
| -11.5 | -17.7 | 14.4 | -- | -- | -- | -- |
|
BSE Healthcare
| 8.9 | 1.6 | 9.0 | 8.7 | 25.0 | 13.7 | 12.2 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Curis Lifesciences
|
106.8 | 88.9 | 49.1 | 6.1 | -- | 55.2 | 12.9 | 1.9 |
| 1,035.0 | 12,853.9 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.8 | 3.9 | |
| 476.6 | 8,257.8 | 947.3 | 247.8 | 28.5 | 18.9 | 33.3 | 6.1 | |
| 1,343.4 | 14,114.8 | 1,054.9 | 256.3 | 27.8 | 13.7 | 54.1 | 7.0 | |
| 1,764.3 | 33,843.8 | 9,203.5 | 941.3 | 15.4 | 19.6 | 36.6 | 6.8 | |
| 389.4 | 4,264.4 | 165.8 | 46.7 | 37.8 | 16.9 | 91.3 | 14.8 | |
| 17,078.0 | 22,077.7 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.7 | 11.8 | |
| 1,128.0 | 5,289.7 | 649.5 | 121.6 | 23.7 | 13.2 | 45.9 | 5.7 | |
| 742.8 | 8,485.8 | 502.0 | 138.7 | -- | 32.8 | 49.1 | 9.6 | |
| 268.2 | 6,897.6 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Curis Lifesciences
--
-
Incorporated
2016
-
Chairman
Dharmesh Dasharathbhai Patel
-
Managing Director
Dharmesh Dasharathbhai Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Curis Lifesciences Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Curis Lifesciences
What is the current share price of Curis Lifesciences Ltd Today?
The share price of Curis Lifesciences Ltd is ₹106.75 (NSE) as of 10-Jun-2026 13:02 IST. Curis Lifesciences Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Curis Lifesciences Ltd?
The P/E ratio of Curis Lifesciences Ltd is 12.86 times as on 09-Jun-2026, a 71 discount to its peers’ median range of 44.89 times.
The P/B ratio of Curis Lifesciences Ltd is 1.88 times as on 09-Jun-2026, a 59 discount to its peers’ median range of 4.60 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
What is the 52 Week High and Low of Curis Lifesciences Ltd?
The 52-week high and low of Curis Lifesciences Ltd are Rs 147.90 and Rs 83.60 as of 10-Jun-2026.
What is the market cap of Curis Lifesciences Ltd?
Curis Lifesciences Ltd has a market capitalisation of ₹ 89 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Curis Lifesciences Ltd?
Before investing in Curis Lifesciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.